Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project.

Annals of the rheumatic diseases·2026
Same author

Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review.

RMD open·2026
Same author

Corrigendum to "Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI)" [Seminars in Arthritis and Rheumatism 78 (2026) 152981].

Seminars in arthritis and rheumatism·2026
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Annals of the rheumatic diseases·2026
Same author

Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI).

Seminars in arthritis and rheumatism·2026
Same author

MRI structural lesions in axSpA: distinguishing outcome measures from diagnostic thresholds.

Annals of the rheumatic diseases·2026

Related Experiment Video

Updated: Jul 10, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Predictive markers in rapidly progressing rheumatoid arthritis.

Robert Landewé1

  • 1Department of Internal Medicine/Division of Rheumatology and Caphri Research Institute, University Hospital Maastricht, Maastricht, The Netherlands.

The Journal of Rheumatology. Supplement
|November 7, 2007
PubMed
Summary

Identifying predictive markers for rheumatoid arthritis (RA) is crucial for personalized treatment. Early detection of aggressive disease and therapy response aids in effective management and resource allocation.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Related Experiment Videos

Last Updated: Jul 10, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Area of Science:

  • Rheumatology and Immunology
  • Clinical Medicine
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) management emphasizes early diagnosis and intervention.
  • Treatment choices are complex due to numerous disease-modifying antirheumatic drugs (DMARDs) with varying efficacy, toxicity, and cost.
  • RA joint damage progression is unpredictable, ranging from self-limited to rapidly destructive forms.

Purpose of the Study:

  • To review established and emerging predictive markers for rheumatoid arthritis outcomes.
  • To identify markers that predict aggressive disease progression and treatment response.
  • To provide a rational basis for early, aggressive RA treatment and optimize healthcare resource allocation.

Main Methods:

  • Literature review of studies on predictive markers in rheumatoid arthritis.
  • Analysis of established prognostic markers in RA management.
  • Evaluation of emerging predictive markers for arthritis outcome.

Main Results:

  • Predictive markers are essential for tailoring RA treatment strategies.
  • Identifying patients with aggressive disease allows for timely, targeted interventions.
  • Markers can prevent overtreatment in patients with less aggressive disease, reducing toxicity and healthcare costs.

Conclusions:

  • The development and application of predictive markers are critical for personalized rheumatoid arthritis care.
  • Predictive markers facilitate rational treatment decisions, improving patient outcomes and resource utilization.
  • Continued research into prognostic markers will refine RA management strategies.